US OptionsDetailed Quotes
CLRB241220P7500
- 0.00
- 0.000.00%
15min DelayTrading Nov 25 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover322.26%IV-360.12%PremiumDec 20, 2024Expiry Date5.87Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9239Delta0.1208Gamma0.28Leverage Ratio-0.0034Theta-0.0024Rho-0.26Eff Leverage0.0006Vega
Cellectar BioSciences Stock Discussion
Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(9.99%)
Cellectar Biosciences and Northstar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
2 MINUTES AGO, 8:05 AM EST
VIA GLOBENEWSWIRE
Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia
Cellectar Biosciences (NASDAQ: CLRB) announced two presentations on iopofosine I 131 at the 12th International Workshop on Waldenstrom's Macroglobulinemia in Prague.
The first presentation by Dr. Jorge Castillo will showcase a case study of complete central nervous system clearance in a patient with Bing-Neel Syndrome (BNS), a rare compli...
No comment yet